Surgery Book

http://www.fpnotebook.com/

Local Lidocaine

Aka: Local Lidocaine, Xylocaine, Lidocaine Local Skin Anesthesia, Buffered Lidocaine
  1. See Also
    1. Local Skin Anesthesia
    2. Digital Block
    3. Lidocaine-Epinephrine-Tetracaine (LET Anesthesia)
    4. EMLA cream
    5. Lidocaine Patch
  2. Preparations
    1. Lidocaine 0.5%, 1%, 2%
  3. Pharmacokinetics
    1. Store at room Temperature (not in refrigerator)
      1. Reduces risk of infection with multi-use bottles
      2. Kirschke (2003) Clin Infect Dis 36:1369-73 [PubMed]
    2. Lidocaine alone (1%, 2%)
      1. Onset: 2 to 5 minutes
      2. Duration: 1.5 to 2 hours
      3. Max dose: 4 mg/kg to 280 mg (14 ml 2%, 28 ml 1%)
    3. Lidocaine with Epinephrine 1:100,000 or 1:200,000
      1. Onset: 2 minutes
      2. Duration: 2 to 6 hours
      3. Max dose: 7 mg/kg to 500 mg (25 ml 2%, 50 ml 1%)
      4. Epinephrine increases Lidocaine's duration of action and maximal safe dose (decreases systemic absorption)
  4. Dosing
    1. Intradermal Lidocaine
      1. See maximum dosing above
  5. Contraindications: Local Lidocaine use
    1. History of allergy to Local Anesthesia
    2. See Local Anesthetic for alternatives if allergy
  6. Contraindications: Combination with local Epinephrine use
    1. Digital Block
    2. Poor vascular supply to an avulsed area
    3. Dirty wound (risk of infection)
    4. Distal organs (relative contraindication)
      1. Previously absolutely contraindicated injection sites: Fingers, Nose, Penis, Toes, Earlobes
      2. More recent data suggests safety (approach as a relative contraindication)
        1. Ilicki (2015) J Emerg Med 49(5):799-809 +PMID: 26254284 [PubMed]
  7. Preparations: Sodium Bicarbonate (Buffered Lidocaine)
    1. Indications
      1. Effective in reducing sting from Local Lidocaine
    2. Dilution 1:10 of 7.5% Sodium Bicarbonate in Xylocaine
    3. Preparation in Syringe (3.5 cc)
      1. Xylocaine: 3 cc
      2. Sodium Bicarbonate: 0.4 cc
    4. Precautions
      1. Shelf-life of Buffered Lidocaine reduced to 1 week
  8. References
    1. Pfenninger (1994) Procedures, Mosby, p. 135-155
    2. Mortiere (1996) Wound Management, p. 27-39
    3. Achar (2002) Am Fam Physician 66(1):91-4 [PubMed]

Xylocaine (C0699094)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D008012
English local anesthetics lidocaine base (Xylocaine), lidocaine base (Xylocaine), xylocaine, Astrazeneca Brand of Lidocaine, Xylocaine
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree